Send the link below via email or IMCopy
Present to your audienceStart remote presentation
- Invited audience members will follow you as you navigate and present
- People invited to a presentation do not need a Prezi account
- This link expires 10 minutes after you close the presentation
- A maximum of 30 users can follow your presentation
- Learn more about this feature in our knowledge base article
Do you really want to delete this prezi?
Neither you, nor the coeditors you shared it with will be able to recover it again.
Make your likes visible on Facebook?
You can change this under Settings & Account at any time.
Nuclear Chemistry in Conjuction with Cancer Patients
Transcript of Nuclear Chemistry in Conjuction with Cancer Patients
They bind to cancer cells, making them more visible to the immune system, which now attaks the unwanted cells.
The antibodies stop the growth signals sent by the cancer cells by blocking the receptors.
Tumors attract blood vessels in order to attain an oxygen and nutrient supply. Monoclonal antibodies block the signals sent by the cells that attract the blood supply. Iodine-131  This isotope is used commonly with thyroid cancer because thyroid cells naturally absorb the iodine. Iodine-131 decays via beta radiation and has a half-life of about 8 days. Samarium-153  This radioactive isotope is used in conjunction with lexidronam; it comes in the form of an injection. The formula is . The samarium has a half-life of 46.3 hours and decays via beta radiation. Strontium-89  This drug is called QUADRAMET. In this case, the radioactive isotope of strontium is bonded to a chloride ion, in a drug called Metastron, which is intravenously dosed. It decays via beta radiation. It has a half-life of 50.5 days. Both Quadramet and Mestastron are palliative drugs, meaning they aren't cures, they just lessen the pain. They are used on patients whose cancers have matastasised to the bone.  Iodine-131 is bonded to tositumomab in a drug called Bexxar, administered in an injection. Tositumomab is a monoclonal antibody composed of various amino acids. It is a matter of weighing risks and benefits  You may be thinking, what's the catch? Unfortunately, radiation therapy doesn't only kill cancer cells, it also kills normal tissue. There is a long list of side effects, some of which are:
decreased blood cell count
vomiting Texts Cited Radiation Therapy for Cancer." National Cancer Institute . National Cancer
Institute , 30 June 2010. Web. 27 Mar. 2011. "X-Ray." MedLine Plus. U.S. National Library of Medicine, 28 Feb. 2011. Web. 27
Mar. 2011. Mayo Clinic. "Monoclonal antibody drugs for cancer treatment: How they work."
Mayo Clinic. Mayo Foundation for Medical Education and Research, 5 Nov.
2010. Web. 3 Apr. 2011. "Iodine." US EPA. US EPA, 24 Mar. 2011. Web. 3 Apr. 2011. <http://www.epa.gov/
rpdweb00/radionuclides/iodine.html>. "QUADRAMET®." RxList. RxList Inc., 2011. Web. 4 Apr. 2011.
. "Metastron." Drugs.com. Drugs.com, 2011. Web. 4 Apr. 2011.
. "BEXXAR® ." RxList. RxList, 2011. Web. 4 Apr. 2011. 1 2 3 4 5 6 7 Images Cited "Bristol-Myers Squibb to Buy Monoclonal Antibody Maker Medarex." BioJob Blog.
LexBlog, 23 July 2009. Web. 3 Apr. 2011. Dave. "What you need to know about laptop radiation." Geek With Laptop.
Prelovac, 14 Sept. 2008. Web. 27 Mar. 2011.
. Pidwirny, Michael, and Scott Jones. "The Nature of Radiation." Physical
Geography. University of British Columbia Okanagan, 29 July 2009. Web.
27 Mar. 2011. "Quadramet." Drugs.com. Drugs.com, 2011. Web. 4 Apr. 2011.
. "Rituximab Failures Show Promising Results with Bexxar." Cancer Watch. N.p.,
Jan. 2001. Web. 4 Apr. 2011. Monoclonal Antibody Pic Radiation Symbol Pic Radiation Spectrum Pic Quadramet Structure Pic Bexxar Pic